Justin Gunesch

Company: Immatics GmbH

Job title: Principal Scientist

Seminars:

Workshop C: Building a Robust Control Strategy in Early-Phase Development of Cell Therapies 1:00 pm

In early-phase development, managing variability in starting materials, such as donor cells and raw materials, is crucial for ensuring consistent and reproducible cell therapy products. This session will explore strategies for establishing control measures that address these challenges and ensure clinical trial success. Establishing Protocols for Starting Material Variability: Developing strategies for sourcing both autologous…Read more

day: Workshop C